About Kyverna Therapeutics
Kyverna Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing cell therapies for patients suffering from B cell-driven autoimmune diseases. The company pioneers next-generation chimeric antigen receptor (CAR) T-cell therapies designed to deeply deplete B cells, reset the immune system, and promote long-lasting, treatment-free remission. Its lead therapeutic candidate, mivocabtagene (miv-cel, KYV-101), is currently advancing through clinical trials for various rheumatology and neurology indications, including lupus nephritis, systemic sclerosis, multiple sclerosis, myasthenia gravis, and stiff person syndrome.
Open Positions0 Roles
No active roles right now
Salary ranges at Kyverna Therapeutics
Estimated compensation ranges based on 0 active job postings.
No salary data available
Kyverna Therapeutics hasn't disclosed salaries for their current open roles. We'll update this section automatically as soon as data becomes available.